Your browser doesn't support javascript.
loading
Development of an abiraterone acetate formulation with improved oral bioavailability guided by absorption modeling based on in vitro dissolution and permeability measurements.
Solymosi, Tamás; Ötvös, Zsolt; Angi, Réka; Ordasi, Betti; Jordán, Tamás; Semsey, Sándor; Molnár, László; Ránky, Soma; Filipcsei, Genovéva; Heltovics, Gábor; Glavinas, Hristos.
Afiliación
  • Solymosi T; NanGenex Inc., 47-49 Madarász Viktor u., Budapest, H-1138, Hungary.
  • Ötvös Z; NanGenex Inc., 47-49 Madarász Viktor u., Budapest, H-1138, Hungary.
  • Angi R; NanGenex Inc., 47-49 Madarász Viktor u., Budapest, H-1138, Hungary.
  • Ordasi B; NanGenex Inc., 47-49 Madarász Viktor u., Budapest, H-1138, Hungary.
  • Jordán T; NanGenex Inc., 47-49 Madarász Viktor u., Budapest, H-1138, Hungary.
  • Semsey S; NanGenex Inc., 47-49 Madarász Viktor u., Budapest, H-1138, Hungary.
  • Molnár L; NanGenex Inc., 47-49 Madarász Viktor u., Budapest, H-1138, Hungary.
  • Ránky S; NanGenex Inc., 47-49 Madarász Viktor u., Budapest, H-1138, Hungary.
  • Filipcsei G; NanGenex Inc., 47-49 Madarász Viktor u., Budapest, H-1138, Hungary.
  • Heltovics G; Druggability Technologies Holdings Ltd. Tower Business Centre, Tower Street, Swatar BKR 4013, Malta.
  • Glavinas H; NanGenex Inc., 47-49 Madarász Viktor u., Budapest, H-1138, Hungary. Electronic address: hristos.glavinas@nangenex.com.
Int J Pharm ; 532(1): 427-434, 2017 Oct 30.
Article en En | MEDLINE | ID: mdl-28919099

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Acetato de Abiraterona Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Int J Pharm Año: 2017 Tipo del documento: Article País de afiliación: Hungria

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Acetato de Abiraterona Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Int J Pharm Año: 2017 Tipo del documento: Article País de afiliación: Hungria